BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gu JJ, Zhang JH, Chen HJ, Wang SS. TPX2 promotes glioma cell proliferation and invasion via activation of the AKT signaling pathway. Oncol Lett 2016;12:5015-22. [PMID: 28105208 DOI: 10.3892/ol.2016.5371] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen S. Glioma Subtypes Based on the Activity Changes of Immunologic and Hallmark Gene Sets in Cancer. Front Endocrinol 2022;13:879233. [DOI: 10.3389/fendo.2022.879233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sun B, Long Y, Xiao L, Wang J, Yi Q, Tong D, Li K, Wu G. Target Protein for Xklp2 Functions as Coactivator of Androgen Receptor and Promotes the Proliferation of Prostate Carcinoma Cells. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/6085948] [Reference Citation Analysis]
3 Cen L, Liu R, Liu W, Li Q, Cui H. Competing Endogenous RNA Networks in Glioma. Front Genet 2021;12:675498. [PMID: 33995499 DOI: 10.3389/fgene.2021.675498] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
4 Chen YN, Hou SQ, Jiang R, Sun JL, Cheng CD, Qian ZR. EZH2 is a potential prognostic predictor of glioma. J Cell Mol Med 2021;25:925-36. [PMID: 33277782 DOI: 10.1111/jcmm.16149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
5 Long N, Chu L, Jia J, Peng S, Gao Y, Yang H, Yang Y, Zhao Y, Liu J. CircPOSTN/miR-361-5p/TPX2 axis regulates cell growth, apoptosis and aerobic glycolysis in glioma cells. Cancer Cell Int 2020;20:374. [PMID: 32774168 DOI: 10.1186/s12935-020-01454-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
6 Liu J, Liang H, Khilji S, Li H, Song D, Chen C, Wang X, Zhang Y, Zhao N, Li X, Gao A. Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells through inhibiting the AKT/mTOR Signalling Pathway. J Cancer 2020;11:5802-11. [PMID: 32913473 DOI: 10.7150/jca.46697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Gu X, Yao X, Liu D. Up-regulation of microRNA-335-5p reduces inflammation via negative regulation of the TPX2-mediated AKT/GSK3β signaling pathway in a chronic rhinosinusitis mouse model. Cell Signal 2020;70:109596. [PMID: 32156642 DOI: 10.1016/j.cellsig.2020.109596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
8 Jiang Y, Liu Y, Tan X, Yu S, Luo J. TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer. Clinical Breast Cancer 2019;19:450-5. [DOI: 10.1016/j.clbc.2019.05.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
9 Johnston WL, Catton CN, Swallow CJ. Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer. BMC Urol 2019;19:4. [PMID: 30616540 DOI: 10.1186/s12894-018-0433-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
10 Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N. Current Challenges and Opportunities in Treating Glioblastoma. Pharmacol Rev. 2018;70:412-445. [PMID: 29669750 DOI: 10.1124/pr.117.014944] [Cited by in Crossref: 227] [Cited by in F6Publishing: 304] [Article Influence: 56.8] [Reference Citation Analysis]
11 Tang J, He D, Yang P, He J, Zhang Y. Genome-wide expression profiling of glioblastoma using a large combined cohort. Sci Rep 2018;8:15104. [PMID: 30305647 DOI: 10.1038/s41598-018-33323-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
12 Yang G, Chen Q, Xiao J, Zhang H, Wang Z, Lin X. Identification of genes and analysis of prognostic values in nonsmoking females with non-small cell lung carcinoma by bioinformatics analyses. Cancer Manag Res 2018;10:4287-95. [PMID: 30349363 DOI: 10.2147/CMAR.S174409] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
13 Zou J, Huang RY, Jiang FN, Chen DX, Wang C, Han ZD, Liang YX, Zhong WD. Overexpression of TPX2 is associated with progression and prognosis of prostate cancer. Oncol Lett 2018;16:2823-32. [PMID: 30127868 DOI: 10.3892/ol.2018.9016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
14 Tian Y, Liu LL, Guo DM, Wang Y, Zha WH, Li Y, Wu FJ. TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in ovarian cancer. J Cell Biochem 2018;119:7540-55. [PMID: 29904936 DOI: 10.1002/jcb.27065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Fan S, Liao Y, Liu C, Huang Q, Liang H, Ai B, Fu S, Zhou S. Estrogen promotes tumor metastasis via estrogen receptor beta-mediated regulation of matrix-metalloproteinase-2 in non-small cell lung cancer. Oncotarget 2017;8:56443-59. [PMID: 28915603 DOI: 10.18632/oncotarget.16992] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]